[go: up one dir, main page]

IT1290839B1 - Acido(-)-(3r)-3-metil-4-(4-(4-piridil) piperazin-1-il)fenossi)butirrico - Google Patents

Acido(-)-(3r)-3-metil-4-(4-(4-piridil) piperazin-1-il)fenossi)butirrico

Info

Publication number
IT1290839B1
IT1290839B1 IT96MI001113A ITMI961113A IT1290839B1 IT 1290839 B1 IT1290839 B1 IT 1290839B1 IT 96MI001113 A IT96MI001113 A IT 96MI001113A IT MI961113 A ITMI961113 A IT MI961113A IT 1290839 B1 IT1290839 B1 IT 1290839B1
Authority
IT
Italy
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
IT96MI001113A
Other languages
English (en)
Italian (it)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ITMI961113A0 publication Critical patent/ITMI961113A0/it
Publication of ITMI961113A1 publication Critical patent/ITMI961113A1/it
Application granted granted Critical
Publication of IT1290839B1 publication Critical patent/IT1290839B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT96MI001113A 1995-06-01 1996-05-31 Acido(-)-(3r)-3-metil-4-(4-(4-piridil) piperazin-1-il)fenossi)butirrico IT1290839B1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (3)

Publication Number Publication Date
ITMI961113A0 ITMI961113A0 (it) 1996-05-31
ITMI961113A1 ITMI961113A1 (it) 1997-12-01
IT1290839B1 true IT1290839B1 (it) 1998-12-14

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001113A IT1290839B1 (it) 1995-06-01 1996-05-31 Acido(-)-(3r)-3-metil-4-(4-(4-piridil) piperazin-1-il)fenossi)butirrico

Country Status (31)

Country Link
EP (1) EP0796247A1 (sv)
JP (1) JP2885941B2 (sv)
KR (1) KR100245957B1 (sv)
AT (1) AT406675B (sv)
AU (1) AU710105B2 (sv)
BE (1) BE1009520A5 (sv)
BR (1) BR9606409A (sv)
CA (1) CA2194397A1 (sv)
CH (1) CH691808A5 (sv)
CZ (1) CZ26997A3 (sv)
DE (1) DE19680509T1 (sv)
DK (1) DK10697A (sv)
ES (1) ES2137886B1 (sv)
FI (1) FI970393L (sv)
GB (1) GB2304340B (sv)
GR (1) GR1002702B (sv)
HU (1) HUP9700274A3 (sv)
IE (1) IE960405A1 (sv)
IL (1) IL118477A0 (sv)
IT (1) IT1290839B1 (sv)
LU (1) LU90008B1 (sv)
MC (1) MC2418A1 (sv)
MX (1) MX9700379A (sv)
NL (1) NL1003243C2 (sv)
NO (1) NO307460B1 (sv)
NZ (1) NZ308597A (sv)
PL (1) PL318440A1 (sv)
SE (1) SE510812C2 (sv)
SK (1) SK13097A3 (sv)
TR (1) TR199700020T1 (sv)
WO (1) WO1996038416A1 (sv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
AU692439B2 (en) * 1993-03-29 1998-06-11 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
PT825184E (pt) * 1993-03-29 2001-11-30 Astrazeneca Ab Derivados heterociclicos como inibidores de agregacao de plaquetas

Also Published As

Publication number Publication date
FI970393A0 (sv) 1997-01-30
BR9606409A (pt) 1997-09-30
AU5827296A (en) 1996-12-18
ES2137886B1 (es) 2000-08-16
SE510812C2 (sv) 1999-06-28
FI970393L (sv) 1997-01-30
IL118477A0 (en) 1996-09-12
GB9627127D0 (en) 1997-02-19
SE9700203D0 (sv) 1997-01-24
JPH09512836A (ja) 1997-12-22
NO307460B1 (no) 2000-04-10
CA2194397A1 (en) 1996-12-05
ITMI961113A1 (it) 1997-12-01
IE960405A1 (en) 1996-12-11
WO1996038416A1 (en) 1996-12-05
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
DK10697A (da) 1997-04-01
HU9700274D0 (en) 1997-04-28
CZ26997A3 (en) 1997-08-13
MC2418A1 (fr) 1997-05-23
NZ308597A (en) 1998-11-25
AU710105B2 (en) 1999-09-16
MX9700379A (es) 1997-04-30
GB2304340A (en) 1997-03-19
GB2304340B (en) 1998-07-29
NO970437L (no) 1997-02-20
JP2885941B2 (ja) 1999-04-26
ES2137886A1 (es) 1999-12-16
SK13097A3 (en) 1997-08-06
SE9700203L (sv) 1997-01-24
LU90008B1 (fr) 1997-04-16
BE1009520A5 (fr) 1997-04-01
DE19680509T1 (de) 1997-12-04
CH691808A5 (de) 2001-10-31
HUP9700274A3 (en) 2000-02-28
HUP9700274A2 (hu) 1999-06-28
KR100245957B1 (ko) 2000-04-01
ATA900596A (de) 1999-12-15
PL318440A1 (en) 1997-06-09
TR199700020T1 (tr) 1997-04-22
NO970437D0 (no) 1997-01-31
GR1002702B (el) 1997-05-22
NL1003243C2 (nl) 1996-12-04
KR970704689A (ko) 1997-09-06
ITMI961113A0 (it) 1996-05-31

Similar Documents

Publication Publication Date Title
DE69617372D1 (de) Datenaufzeichnungs-/-wiedergabeverfahren
MX9906600A (es) 4-(3-heterociclil-1-benzoil)pirazoles
FI944955A0 (sv) Förfarande för stärkning av cellulosasubstrat
TR199800783T2 (xx) (-) C�s-6(S)-Fenil-5(R)$4-(2-Pirolidin-1-�letoksi) Fenil]-5,6,7,8-Tetrahidronaftalen-2-ol-d-tartrat
DE69428830D1 (de) Datendemultiplexer
NO953658D0 (no) Fremgangsmåte for fremstilling av 3-[4-(2-aminoetoksy)-benzoylÅ-2-aryl-6-hydroksybenzo[bÅtiofener
DE69530520D1 (de) Computerprogrammprodukt zur Verwendung von Mehrfachbefehlssätzen
PT907650E (pt) N-¬4-(heteroarilmetil)fenil|heteroarilaminasc
FI981280A0 (sv) Förfarande för extern limning av fiberartade material
DE69606053D1 (de) Modifizierte fluorsulfonsäure
EE200000123A (et) Meetod kontaktandmete uuendamiseks
FI940316L (sv) Förfarande för fraktionering av vassleproteiner
IT1290839B1 (it) Acido(-)-(3r)-3-metil-4-(4-(4-piridil) piperazin-1-il)fenossi)butirrico
ID25536A (id) Metode pembuatan asam-asam 4-fenil-4-sianosikloheksanoat tersubstitusi
FI954123L (sv) Förfarande för supression av glukosrepression
FI972881L (sv) Defibreringsförfarnade
NO963218D0 (no) Para-hydroksyfenyleddiksyre for reduksjon av frastötningsevnen av insekticider
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
DE59811763D1 (de) Substituierte 4-(3-alkenyl-benzoyl)-pyrazole
DE69631878D1 (de) Clavulansäure extraktionsverfahren
DE59812950D1 (de) Magnetbandkassettengerät
ITPG950012V0 (it) Contromarca (fox room)
DE59804199D1 (de) Verfahren zur isolierung von 3-[2-chlor-4-(trifluormethyl)-phenoxy]-benzoesäure
KR960024892U (ko) 모노 비디오 카세트 플레이어

Legal Events

Date Code Title Description
0001 Granted